Thieme E-Books & E-Journals -
Zurück
Pharmacopsychiatry 2009; 42(1): 14-19
DOI: 10.1055/s-0028-1085438
Original Paper

© Georg Thieme Verlag KG Stuttgart · New York

Rosiglitazone in the Assistance of Metabolic Control during Olanzapine Administration in Schizophrenia: A Pilot Double-blind, Placebo-controlled, 12-week Trial

T. Baptista 1 , N. Rangel 2 , Y. El Fakih 3 , E. Uzcátegui 3 , T. Galeazzi 4 , S. Beaulieu 5 , E. Araujo de Baptista 6
  • 1Department of Physiology, Los Andes University Medical School, Mérida, Venezuela
  • 2Psychiatric Institute “Dr. Raúl Castillo”, Peribeca, San Cristóbal, Táchira State, Venezuela
  • 3Department of Psychiatry, Los Andes University Medical School, Mérida, Venezuela
  • 4LABIMET, Los Andes University Medical School, San Cristóbal, Venezuela
  • 5Douglas Hospital Research Center, McGill University, Montreal, QC, Canada
  • 6Pharmacy School, Department of Microbiology, Los Andes University Medical School, Mérida, Venezuela